Genasys amends loan agreement with Maran Partners Fund; amount not stated in filing
Genasys Inc. entered into a First Amendment to its loan agreement with Maran Partners Fund, LP, dated September 14, 2026, and reported it under Item 2.03 as a direct financial obligation. The filing does not state the amendment's amount, interest rate, maturity or changed terms in the text provided, so shareholders cannot yet judge its size or cost from this document.
Key points
- Amendment is dated September 14, 2026, between Genasys Inc. and Maran Partners Fund, LP (Exhibit 10.1).
- The filing is made under Items 1.01, 2.03 and 9.01; the Item 1.01 disclosure it incorporates is not included in the text provided.
- No loan amount, interest rate or revised repayment terms are stated in the text provided.
- Filing was signed by Chief Financial Officer Cassandra L. Hernandez-Monteon.
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 14, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.